A comparison of d,l-fenfluramine and citalopram challenges in healthy adults

Psychopharmacology

Volumn 174, Issue 3, 2004, Pages 376-380

  Flory, Janine D ^a   Manuck, Stephen B ^a   Perel, James M ^b   Muldoon, Matthew F ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Citalopram; d,l fenfluramine; Serotonin

Indexed keywords

CITALOPRAM; FENFLURAMINE; PROLACTIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE SENSITIVITY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; SINGLE DRUG DOSE;

EID: 3843112287     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1763-9     Document Type: Article

References (22)

1. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155:323-326
2. Bhagwagar Z, Whale R, Cowen PJ (2002) State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 180:24-28
3. Borroni E, Ceci A, Garrattini S, Mennini T (1983) Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. J Neurochem 40:891-893
4. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46:587-599
5. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Sclaff HV (1997) Valvular heart disease associated with fenfluramine- phentermine. N Engl J Med 337:581-588
6. Evans J, Platt H, Lightman S, Nutt D (2000) Impulsiveness and the prolactin response to d-fenfluramine. Psychopharmacology 149:147-152
7. Flory JD, Mann JJ, Muldoon M, Manuck SB (1998) Recovery from major depression is not associated with normalization of serotonergic function. Biol Psychiatry 43:320-326
8. Flory JD, Manuck SB, Muldoon MF (2002) Retest reliability of prolactin response to dl-fenfluramine challenge in adults. Neuropsychopharmacology 26:269-272
9. Golden RN, Gilmore JH, Ekstrom RD, Knight B, Ruegg RG, Miller HL, Carson SW (1996) The effects of age, gender and season on serotonergic function in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 20:1315-1323
10. Hennig J, Netter P (2002) Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Intl J Neuropsychopharmacol 5:67-71
11. Hiemke C, Härtter H (2000) Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85:11-28
12. Joubert AF, Sanchez C, Larson F (2000) Citalopram. Hum Psychopharmacol 15:439-451
13. Kapitany T, Schindl M, Schindler SD, Hebelmann B, Fureder T, Barnas C, Sieghart W, Kasper S (1999) The citalopram challenge test in patient with major depression and in healthy controls. Psychiatry Res 88:75-88
14. Malone KM, Corbitt EM, Li S, Mann JJ (1996) Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324-329
15. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF (1998) Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19:287-299
16. McBride PA, Tierney H, DeMeo M, Chen J-S, Mann JJ (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27:1143-1155
17. Murphy DL, Mellow AM, Sunderland T, Aulakh CS, Lawlor BL, Zohar J (1990) Strategies for the study of serotonin in humans. In: Coccaro EF, Murphy DL (eds) Serotonin in major psychiatric disorders. American Psychiatric Press, Washington D.C., pp 2-25
18. Netter P, Toll C, Lujic C, Reuter M, Hennig J (2002) Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems. Behav Pharmacol 13:441-449
19. O'Keane V, McLoughlin D, Dinan TG (1992) d-Fenfluramine-induced prolactin and Cortisol celease in major depression: response to treatment. J Affect Disord 26:143-150
20. Seifritz E, Baumann P, Muller MJ, Annen O, Amey M, Hemmeter U, Hatzinger M, Chardon F, Holsboer-Trachsler E (1996) Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. Neuropsychopharmacology 14:253-263
21. Soloff PH, Kelly TM, Strotmeyer SJ, Malone KM, Mann JJ (2003) Impulsivity, gender and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 119:11-24
22. Yatham LN, Steiner M (1993) Neuroendocrine probes of serotonergic function: a critical review. Life Sci 53:447-463